Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04697979
Status:
UNKNOWN
Last Update Posted:
2021-01-06
First Post:
2021-01-04
Brief Title:
Post-Stroke Medication Relay
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Post-Stroke Medication Relay
Status:
UNKNOWN
Status Verified Date:
2021-01
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REMEDIPA
Brief Summary:
Prior to discharge from hospital and return home patients managed for ischemic stroke will receive a pharmaceutical interview to discuss their discharge prescription indication method of administration precautions and possible side effects
Improvements in the use of medications in the community and in hospital follow-up
Telephone interviews or teleconsultations will make it possible to assess the patients knowledge of his or her treatment and to re-explain it if necessary to improve patient compliance with treatment
Improvements in the use of medications in the community and in hospital follow-up
Telephone interviews or teleconsultations will make it possible to assess the patients knowledge of his or her treatment and to re-explain it if necessary to improve patient compliance with treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None